|
|
|
| |
Tuesday, May 1, 2007 |
|
 |
|
 |
| |
| Vioxx and heart disease - FDA Says No to Vioxx Successor - Washington |
FDA successor does not say to the Vioxx -WashingtonPost
FDA does not say VioxxSuccessorWashington to post, DC April 27, 2007Sincepulling Vioxx of the market, to Merck more than 10000 processes of theformer patients and vioxx and heart disease their families confronted. To more informationover heart illness...
Source:news.google.com
Analysis:FDA improving calculation of successes senate -PresseInternational
Analysis combined: FDA improvecalculation ErfolgeSenateUnited press International 18 hours,AgoPostmarketing, which became monitoring a main expenditure, sincethe Agenturblindsided does not say effectively by increased heartcontainer dangers that pain drug Vioxx... in
Sourcewar:news.google.com
FDA to theVioxxNachfolger - HealthCentral.com
FDA does not say toVioxxSuccessorHealthCentral.com, VA April 27, 2007Vioxxvommarket in September 2004 was taken back, according to the studies,which were it-shown, doubled the danger for heart attack and vioxx and heart disease anschlag.Bextra became for...
Sourcezurueckgenommen:news.google.com
Pharmasector: Few personality of the week - Merck, Novartis... -HandelnderMarkets
Pharma sector: Few personality of theweek Merck, Novartis... acting markets, CA April28,2007Arcoxia, regarded as successors to the withdrawn DrogeVioxx,rejected of the panel of experts of the Arthritis of the FDA anApril12...
Source:news.google.com
Anothercoxib fuerArthritis? FDA taefeln says NO - Americanmedical-oh-arranged (more subscription)
Another coxibfuerArthritis? FDA taefeln says noAmerican medicalNachrichten(subscription) April to 29, 2007Two of the threedrugs thereby, group of that -- Vioxx (rofecoxib) and vioxx and heart disease Bextra(valdecoxib) -- by the market 2004und 2005 was taken back, and vioxx and heart disease /orbecause...
Source: news.google.com
|
| posted by vioxx and heart disease @ Tuesday, May 1, 2007
|
|
|
|
|
 |
|
 |
|
|
|
 |
|
